These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1863728)

  • 1. Pharmacokinetics of dantrolene in an adult patient undergoing cardiopulmonary bypass.
    Comunale ME; DiNardo JA; Schwartz MJ
    J Cardiothorac Vasc Anesth; 1991 Apr; 5(2):153-5. PubMed ID: 1863728
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiopulmonary bypass interference with dantrolene prophylaxis of malignant hyperthermia.
    Larach DR; High KM; Larach MG; Hensley FA; Martin DE; Williams DR
    J Cardiothorac Anesth; 1987 Oct; 1(5):448-53. PubMed ID: 2979114
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of intravenous dantrolene in children.
    Lerman J; McLeod ME; Strong HA
    Anesthesiology; 1989 Apr; 70(4):625-9. PubMed ID: 2929999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is the prevention of peranesthetic malignant hyperthermia with dantrolene justified?].
    Welfringer P; Cornet C
    Ann Fr Anesth Reanim; 1988; 7(5):437-8. PubMed ID: 3207236
    [No Abstract]   [Full Text] [Related]  

  • 5. Dantrolene-induced hyperkalemia in a patient treated with diltiazem and metoprolol.
    Yoganathan T; Casthely PA; Lamprou M
    J Cardiothorac Anesth; 1988 Jun; 2(3):363-4. PubMed ID: 17171874
    [No Abstract]   [Full Text] [Related]  

  • 6. Rewarming following hypothermic cardiopulmonary bypass in the malignant hyperthermia-susceptible patient: implications for diagnosis and perioperative management.
    Allen GC; Cattran CB
    Can J Anaesth; 1989 Jan; 36(1):81-5. PubMed ID: 2914339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presumed Malignant Hyperthermia Treated During Cardiopulmonary Bypass in a Pediatric Patient Undergoing Aortic Valve Replacement: A Case Report.
    Kuntz MT; Saab AD
    A A Pract; 2019 Apr; 12(7):246-248. PubMed ID: 30299295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sevoflurane-induced malignant hyperthermia during cardiopulmonary bypass and moderate hypothermia.
    Jonassen AA; Petersen AJ; Mohr S; Andersson C; Skattum J; Kvernebo K; Paulsen OG; Stokland O; Kirkebøen KA
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):1062-5. PubMed ID: 15315628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of malignant hyperthermia obscured by cardiopulmonary bypass.
    MacGillivray RG; Jann H; Vanker E; Gemmell L; Mahomedy AE
    Can Anaesth Soc J; 1986 Jul; 33(4):509-14. PubMed ID: 3742327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Almost-certain malignant hyperthermia during cardiopulmonary bypass: a case report and literature review.
    Zhang Y; Zhou R
    Perfusion; 2019 Sep; 34(6):490-494. PubMed ID: 30843472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report.
    Friesen CM; Brodsky JB; Dillingham MF
    Can Anaesth Soc J; 1979 Jul; 26(4):319-21. PubMed ID: 509349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiovascular effects of dantrolene sodium in dogs.
    Ellis RH; Simpson P; Tatham P; Leighton M; Williams J
    Anaesthesia; 1975 May; 30(3):318-22. PubMed ID: 1147175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hemodynamic effects of dopamine following cardiopulmonary bypass.
    Merin G; Bitran D; Uretzky G; Superstine E; Cotev S; Borman JB
    Ann Thorac Surg; 1977 Apr; 23(4):361-3. PubMed ID: 849049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulatory effects of propranolol and cardiopulmonary bypass.
    Tyers GF; Hughes HC
    J Surg Res; 1975 Feb; 18(2):181-4. PubMed ID: 1134084
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dantrolene and malignant hyperthermia].
    Grote B
    Anaesthesist; 1982 May; 31(5):211-2. PubMed ID: 7103028
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prophylactic use of oral dantrolene for spinal anesthesia in a patient with susceptible malignant hyperthermia].
    Shindoh M; Enomoto K; Tatekawa S; Yukioka H; Yoshimoto N; Fujimori M
    Masui; 1988 Jul; 37(7):861-7. PubMed ID: 3230633
    [No Abstract]   [Full Text] [Related]  

  • 17. Effective use of dantrolene in a patient susceptible to malignant hyperthermia.
    Gallagher DM; Hyer RL
    J Oral Surg; 1980 Jun; 38(6):438-40. PubMed ID: 6929328
    [No Abstract]   [Full Text] [Related]  

  • 18. Secretion of dantrolene into breast milk after acute therapy of a suspected malignant hyperthermia crisis during cesarean section.
    Fricker RM; Hoerauf KH; Drewe J; Kress HG
    Anesthesiology; 1998 Oct; 89(4):1023-5. PubMed ID: 9778021
    [No Abstract]   [Full Text] [Related]  

  • 19. ECT use for a patient with malignant hyperthermia.
    Franks RD; Aoueille B; Mahowald MC; Masson N
    Am J Psychiatry; 1982 Aug; 139(8):1065-6. PubMed ID: 7091436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
    Ward A; Chaffman MO; Sorkin EM
    Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.